Willow connects eligible patients with board-certified doctors for GLP-1 weight loss treatment, providing convenient online assessments and discreet home delivery
General eligibility typically requires age 18 or older, BMI 30 or higher (27 or higher with a comorbidity), and no current GLP-1 medication use
Glow and even-looking tone usually improve slowly with regular care
Factors like starting weight, baseline metabolism, and adherence to injections all influence this timeline
Glucagon-like peptide-1 agonists (GLP-1RA, GLP-1DAs, incretin mimetics, or GLP-1 analogs) represent a category of therapeutics used in the treatment of type 2 diabetes mellitus (T2DM) and obesity
These unstable molecules are called free radicals, and the oxidative damage they cause can increase the risk of heart disease, liver disease, some cancers, and other conditions